Skip to ContentSkip to Navigation
About us Latest news News News articles

Immunotherapeutic strategies in patients with solid malignancies. Crossing the line between scientific possibility and clinical reality

05 September 2012

PhD ceremony: Ms. C.J. Voskens, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Immunotherapeutic strategies in patients with solid malignancies. Crossing the line between scientific possibility and clinical reality

Promotor(s): prof. H.W. Nijman, prof. D.L. Mann, prof. S.E. Strome

Faculty: Medical Sciences

Increasing clinical data suggest that eradication of human cancer may best be accomplished by concurrent activation of the various components of the immune system. This may be achieved by combining cancer treatment modalities which are able to enhance antitumor immune responses within the innate or adaptive immune system, by combing cancer treatment modalities, which simultaneously activate both innate and adaptive immunity or by combining treatment modalities, which stimulate tumor-specific immunity and target co-stimulatory pathways.

Last modified:13 March 2020 01.01 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.